| 000 | 01575 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513102510.0 | ||
| 264 | 0 | _c19970103 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColombat, P | |
| 245 | 0 | 0 |
_aGranulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cAug 1996 |
||
| 300 |
_a293-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aLymphoma _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aDelain, M | |
| 700 | 1 | _aDesbois, I | |
| 700 | 1 | _aDomenech, J | |
| 700 | 1 | _aBinet, C | |
| 700 | 1 | _aTabah, I | |
| 700 | 1 | _aLamagnere, J P | |
| 700 | 1 | _aLinassier, C | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 18 _gno. 2 _gp. 293-9 |
|
| 999 |
_c8857229 _d8857229 |
||